- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01621139
A Pilot Clinical Trial to Evaluate the Effects of Acupuncture in Patients on Prolonged Mechanical Ventilation
November 12, 2013 updated by: Ognjen Gajic, Mayo Clinic
A Pilot Prospective Randomized Study to Evaluate the Effects of Acupuncture in Patients on Prolonged Mechanical Ventilation
The purpose of this study is to investigate the role of acupuncture use on: 1) decrease the requirements for pharmacologic analgesic, 2) improve patient-reported pain, 3) expedite recovery process, and 4) improve the quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55902
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Consecutive male and post-menopausal female patients expected to require more than 24 hours of mechanical ventilation will be included.
Exclusion Criteria:
- Children < 18 years of age
- Patients with active resuscitation (fluid boluses greater than 2 Liter per hour, rapid transfusions, titration of vasoactive medication)
- Patients with hemodynamic instability: heart rate less than 40/min or greater than 120/min, SBP < 90 or > 180 mm Hg for longer than 2 continuous hours
- Patients who are pregnant or pre-menopausal
- Patients with expected survival less than 6 3 months
- Major deformities of the upper or lower extremities and/or any active skin lesions or ulcers in acupuncture treatment areas.
- Patients with a pacemaker or other implanted electronic device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real acupuncture
Real acupuncture group
|
Patients on mechanical ventilation greater than two days will be randomly assigned to real acupuncture group or sham acupuncture group
|
|
Sham Comparator: Sham acupuncture
Sham acupuncture group
|
Patients on mechanical ventilation greater than two days will be randomly assigned to real acupuncture group or sham acupuncture group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
RASS (Richmond Agitation Sedation Scale)
Time Frame: baseline to six months
|
baseline to six months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ABPS (Aberdeen Back Pain Scale)
Time Frame: baseline to six months
|
baseline to six months
|
|
Pain Scale
Time Frame: baseline to six months
|
baseline to six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
March 29, 2012
First Submitted That Met QC Criteria
June 15, 2012
First Posted (Estimate)
June 18, 2012
Study Record Updates
Last Update Posted (Estimate)
November 13, 2013
Last Update Submitted That Met QC Criteria
November 12, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 09-001937
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.